The COST Action BM1304, "Applications of MR imaging and spectroscopy techniques in neuromuscular disease: collaboration on outcome measures and pattern recognition for diagnostics and therapy development", was approved by the COST Committee of Senior Officials on 15 May 2013. It was formally launched on 2 December 2013.


  • Improve diagnosis and understanding of muscle pathology: online atlas
  • Develop multicentric imaging outcome measures: SOPs
  • Explore new contrasts, targets and imaging techniques for NMD: clinical testing
  • Explore strategies for muscle imaging texture analysis: validated algorithms